Award #HT94252390006

Award for Regenerative Therapy Research to Medical Technology Enterprise Consortium

This award represents a new Other Transaction (OT) agreement under the Medical Technology Enterprise Consortium (MTEC) contract vehicle, specifically targeting research on innovative treatments for corneal injuries using enhanced regenerative therapy. The recipient, Medical Technology Enterprise Consortium, is a collaborative organization focused on advancing medical technologies, particularly in regenerative medicine, aligning well with the goal of this contract. The scope of work involves developing and evaluating new therapeutic methods to improve recovery outcomes for corneal injuries, contributing significant advancements to ophthalmologic treatments and potential public health benefits. This contract is part of a broader multi-year effort under a prior Phase I Other Transaction Agreement with MTEC, indicating ongoing research and development commitment in this domain. Awarded as a supplemental agreement to the existing parent contract, it ensures continuity and expansion of foundational work. While specific solicitation details are not available, the award underscores the importance of innovative biomedical research in government health initiatives. The period of performance spans approximately two years, reflecting a medium-term project timeline dedicated to achieving substantial therapeutic progress.

Description

NEW OT FOR PROJECT MTEC-22-02-MPAI-005, "TREATMENT OF CORNEAL INJURIES WITH AN ENHANCED REGENERATIVE THERAPY"

View original record